Intelligent Bio Solutions publishes investor deck on fingerprint sweat-based drug screening system

Intelligent Bio Solutions outlined its fingerprint-sweat drug screening system, targeting a 16–24 hour detection window to better indicate potential impairment.

The system workflow calls for a 5-second fingertip collection, cartridge insertion into a reader, and results in under 10 minutes. A faster cartridge study targets 70% quicker results.

The company reported 480+ active accounts across 35 countries and territories, with 1,800+ readers installed.

Fiscal Q3 gross margin was 50.5%. Q3 revenue rose 46% year over year to $1.06 million, and Q3 cartridge sales increased 59% to $703,538.

Nine-month revenue increased 39% year over year to $3.07 million. The company said its manufacturing partnership targets over 40% annual production cost savings.